The estimated Net Worth of David E. Sveen is at least $2.58 Milione dollars as of 17 February 2022. David Sveen owns over 8,571 units of Heska stock worth over $2,465,315 and over the last 11 years he sold HSKA stock worth over $0. In addition, he makes $113,477 as Independent Director at Heska.
Sign up
David Sveen HSKA stock SEC Form 4 insiders trading
David has made over 3 trades of the Heska stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 8,571 units of HSKA stock worth $283,357 on 17 February 2022.
The largest trade he's ever made was buying 21,428 units of Heska stock on 30 November 2014 worth over $299,992. On average, David trades about 2,482 units every 176 days since 2013. As of 17 February 2022 he still owns at least 20,546 units of Heska stock.
You can see the complete history of David Sveen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Sveen biography
Dr. David E. Sveen Ph.D. serves as Independent Director of the Company. He is the Executive Chair and Managing Director of Cedarstone, an operations, analytics and strategy consulting practice for nonprofit organizations, which he founded in 1993. He is also currently the President of the Domanada Foundation. His professional background includes 13 years in senior management with investment banking firm Griffin, Kubik, Stephens and Thompson, an adjunct assistant professorship of Christian Formation and Ministry at Wheaton College since 1995 and service on several profit and nonprofit boards. Dr. Sveen holds a Ph.D. degree from Trinity Evangelical Divinity School, an MBA from DePaul University, an MA from Wheaton Graduate School, and a B.S. degree from Northern Illinois University. Dr. Sveen brings to the board extensive leadership experience, financial and accounting knowledge and executive level management capability.
What is the salary of David Sveen?
As the Independent Director of Heska, the total compensation of David Sveen at Heska is $113,477. There are 12 executives at Heska getting paid more, with Jason Aroesty having the highest compensation of $3,495,150.
How old is David Sveen?
David Sveen is 63, he's been the Independent Director of Heska since 2016. There are 2 older and 14 younger executives at Heska. The oldest executive at Heska Corp. is Bonnie Trowbridge, 73, who is the Independent Director.
What's David Sveen's mailing address?
David's mailing address filed with the SEC is Heska, 3760, Rocky Mountain Avenue, Loveland, Larimer County, Colorado, 80538, United States.
Insiders trading at Heska
Over the last 22 years, insiders at Heska have traded over $40,831,198 worth of Heska stock and bought 747,946 units worth $2,470,701 . The most active insiders traders include Jason A Napolitano, Robert B Grieve e Robert L Antin. On average, Heska executives and independent directors trade stock every 20 days with the average trade being worth of $1,041,873. The most recent stock trade was executed by Kevin S. Wilson on 6 January 2023, trading 11,018 units of HSKA stock currently worth $645,875.
What does Heska do?
heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a
What does Heska's logo look like?
Complete history of David Sveen stock trades at Heska
Heska executives and stock owners
Heska executives and other stock owners filed with the SEC include:
-
Jason Aroesty,
Executive Vice President - International Diagnostics -
Catherine Grassman,
Chief Financial Officer, Executive Vice President -
Kevin S. Wilson,
CEO, Pres & Director -
Kevin Wilson,
President, Chief Executive Officer, Director -
Catherine I. Grassman CPA,
Exec. VP & CFO -
Steven M. Eyl,
Exec. VP, Chief Commercial Officer & Pres of scil animal care company -
Dr. Nancy Wisnewski,
Exec. VP & COO -
Nancy Wisnewski,
Chief Operating Officer, Executive Vice President -
Steven Eyl,
Executive Vice President, Chief Commercial Officer, Heska and President, scil animal care -
Scott Humphrey,
Independent Chairman of the Board -
Bonnie Trowbridge,
Independent Director -
Sharon Larson,
Independent Director -
David Sveen,
Independent Director -
Mark Furlong,
Independent Director -
Robert Antin,
Director -
Jon Aagaard,
Director, Investor Relations -
Stephen Davis,
Director -
Christopher Sveen,
Executive Vice President, Chief Administrative Officer and General Counsel, Heska and President, Diamond Animal Health -
Anthony C. Providenti Jr.,
Exec. VP of Corp. Devel. -
Laurie E. Peterson,
VP of Heska Des Moines -
Daniel J. Pollack,
VP of Imaging Operations, Treasurer & Assistant Sec. -
Eleanor F. Baker,
Exec. VP, MD & COO of scil animal care company -
Jason D. Aroesty,
Exec. VP of Global Sales and Marketing -
Steve Asakowicz,
EVP, Comp. Animal Health Sales -
Carol Wrenn,
Director -
Rod Lippincott,
EVP, Comp. Animal Health Sales -
John Mc Mahon,
VP, Fin. Oper. & Controller -
Michael J Mc Ginley,
EVP, Global Operations -
G Irwin Gordon,
Director -
John R Flanders,
V.P., General Counsel -
Gerald L Snodgrass,
VP, Sales -
Coast Investors Ltd Pacific,
10% owner -
Joseph H Ritter,
VP, Marketing & Int'l Bus. -
Ventures Ii, L.P.Charter Ve...,
-
A Barr Dolan,
Director -
Carol Talkington Verser,
Exec.V.P. Intel Prop & Bus Dev -
Lynnor B Stevenson,
Director -
Life Sciences I Iv Llc Charter,
10% owner -
Elisabeth H Demarse,
Director -
Tina Susan Nova,
Director -
Ventures Ii, L.P. Charter,
10% owner -
Lyle A Hohnke,
Director -
Dan T Stinchcomb,
Exec. V.P., Research and Dev. -
Albert Jr Honsch,
Vice President, Sales -
Jason A Napolitano,
Chief Strategy Officer -
Robert B Grieve,
Chief Executive Officer -
William A Aylesworth,
Director -
Joseph Aperfine,
EVP, Sales and Marketing -
Master Fund, L.P.Cmc Master...,
-
Michael A Bent,
V.P.Actg. Officer & Controller -
Claudine Zachara,
-
Master Fund, L.P.Cmc Master...,
-
John F Sasen,
Director -
Peter Eio,
Director -
Louise L. Mc Cormick,
Director -
Joachim A. Hasenmaier,
-
Eleanor F. Baker,
EVP, Managing Dir. & COO, scil -
Anthony C. Jr. Providenti,
EVP, Corporate Development -
Sharon J. Maples,